| Sally Lynn O'malley, CCC-SLP | |
|
998 Barton Ave Nw, Buffalo, MN 55313-4401 | |
| (763) 682-9011 | |
| (763) 682-9011 |
| Full Name | Sally Lynn O'malley |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 998 Barton Ave Nw, Buffalo, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164687026 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7720 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sally Lynn O'malley, CCC-SLP 998 Barton Ave Nw, Buffalo, MN 55313-4401 Ph: (763) 682-9011 | Sally Lynn O'malley, CCC-SLP 998 Barton Ave Nw, Buffalo, MN 55313-4401 Ph: (763) 682-9011 |
News Archive
Hospital admissions at Stony Brook University Medical Center on Long Island were significantly reduced when using coronary computed tomographic angiography (CCTA) to evaluate patients presenting in the emergency department (ED) with acute chest pain (ACP), according to research results presented during a scientific session at the American College of Cardiology's 60th Annual Scientific Session and Expo in New Orleans on April 3.
The Wall Street Journal reports that drug companies are increasingly using medical science liaisons: "Pharmaceutical companies are barred by the Food and Drug Administration from promoting unapproved drug uses, called off-label use, but they are using employees called 'medical science liaisons,' who are often physicians and pharmacists, as a legal way to discuss those uses.
Karolinska Development AB today announced that the European Investment Fund (EIF) has entered into a co-investment agreement with the company. The co-investment fund will be managed by Karolinska Development and used to invest in the company's portfolio of early-stage pharmaceutical and medical technology companies.
TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world's first clinical trials site for a new drug designed to halt cancer cell division.
› Verified 1 days ago
Rachel Ilstrup, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 1st Ave S, Buffalo, MN 55313 Phone: 763-682-7774 | |
Mrs. Caitlin Mcclung Hiemenz, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 1st Ave S, Buffalo, MN 55313 Phone: 763-682-7774 | |
Jennifer Swanson, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 300 Catlin St, Suite 101, Buffalo, MN 55313 Phone: 763-684-3867 | |
Heidi Wolak-faber, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Catlin St, Suite 100, Buffalo, MN 55313 Phone: 763-682-2202 Fax: 763-682-2439 | |
Ashley Woolison, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 1st Ave S, Buffalo, MN 55313 Phone: 763-682-2312 | |
Kelsey Wiebusch, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 1st Ave S, Buffalo, MN 55313 Phone: 763-682-7774 |